VYVGART® Hytrulo is the first and only neonatal Fc receptor (FcRn) blocker that is delivered as a subcutaneous injection, approved to treat chronic inflammatory demyelinating polyneuropathy (CIDP) CIDP is the second FDA-approved indication for VYVGART® Hytrulo with ENHANZE® SAN DIEGO,…

NEW YORK, June 21, 2024 /PRNewswire/ –The global electromagnetic interference (EMI) shielding market size is estimated to grow by USD 3530.9 mn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 7.27% during the forecast period. Growth in global…

NEW YORK, June 21, 2024 /PRNewswire/ — The global alcoholic beverages market size is estimated to grow by USD 261.6 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 2.09% during the forecast period. Increase in popularity of craft segment is…

NEW YORK, June 21, 2024 /PRNewswire/ — The global hospital infection therapeutics market size is estimated to grow by USD 3.46 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.27% during the forecast period. Increase in incidence and…

NEW YORK, June 21, 2024 /PRNewswire/ — The global smart office solutions market size is estimated to grow by USD 3.96 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 15.65% during the forecast period. Increase in number of startups is…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.